Published in this latest issue of the New England Journal of Medicine, this article recounts the lessons we’ve learned in addressing the HIV pandemic in Africa and how those lessons could and should be used to inform COVID-19 vaccine access in Africa. Infrastructure, stigma, acceptability of treatment/vaccines, and delays in safety of drugs among pregnant women and children have long stagnated progress in HIV elimination, and these factors will also affect COVID-19 prevention in low-income countries.
Explore Related Resources
Malawi landscape
Journal Articles
Barriers and facilitators to 6 monthly multi-month dispensing of antiretroviral therapy in HIV clinics during the COVID-19 Era in Malawi
Published December 2024
Following the COVID-19 pandemic, the Malawi Government released a policy that promoted the scale-up of six-monthly multi-month dispensing (6-MMD) of antiretroviral therapy (ART) to people living with HIV in order to decrease congestion at health facilities and transmission of COVID-19. We evaluated the barriers and facilitators to implementing the scale-up of 6-MMD.We conducted a cross-sectional […]
View Resource
Topics:
Global Health Security
Countries:
Malawi
Journal Articles
Implementing SARS-CoV-2 Testing during a Large-Scale Sporting Event in Africa
Published December 2024
During the 33rd Africa Cup of Nations (AFCON) football tournament in Cameroon, organizers and health authorities required a negative SARS-CoV-2 test result <48 hours before entry and provided free SARS-CoV-2 testing and vaccination at stadium and fan zone entrances. We describe the outcomes and implementation of mandatory SARS-CoV-2 testing at fan zones during AFCON. All […]
View Resource
Topics:
Global Health Security
Countries:
Cameroon
A rider delivering blood samples from facilities to Mbita sub county hospital, Mbita,Homabay. Photo by Kevin Ouma for EGPAF
Journal Articles
Integrating SARS-CoV-2 rapid antigen testing in maternal, neonatal and child health, HIV, and TB clinics in Kenya and Cameroon
Published October 2024
Introduction: Early diagnosis of SARS-CoV-2 infection is key to preventing severe disease and poor outcomes in vulnerable populations, such as pregnant women and people living with HIV or diagnosed with tuberculosis (TB). We assessed outcomes achieved with the integration of SARS-CoV-2 antigen-detecting rapid diagnostic testing (Ag-RDT) into maternal, neonatal and child health (MNCH); HIV and TB […]
View Resource
Topics:
Global Health Security,
Maternal and Child Health
Countries:
Cameroon,
Kenya